Assessment of Color Vision in Diabetic Patients

Assessment of color vision in diabetic patients before and after the use of anti-vegf in the treatment of diabetic macular edema

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Retinopathy, Diabetic Cardiovascular Diseases Diabetes Complications Diabetes Mellitus Diabetic Angiopathies Diabetic Retinopathy Endocrine System Diseases Eye Diseases Retinal Diseases Vascular Diseases

Age range

1 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Instituto de Olhos de Goiania

Goiânia, Goiás, 74110120, Brazil

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Having diabetic retinopathy with macular edema

Exclusion criteria

Not having diabetic retinopathy with macular edema

Treatment and study plan

Lucentis

Drug

Use of lucentis and other anti-vegf in patients with diabetic retinopathy

Primary outcomes

Assessment of color vision in diabetic patients before and after the use of anti-vegf in the treatment of diabetic macular edema

Time frame: 3 months

Using the Ishihara's test to analise the possible loss of vision

Secondary outcomes

Frame between the injections

Time frame: 1 months

Ant-Vegf

Sponsors and collaborators

Lead sponsor

Instituto de Olhos de Goiania

Other

Registry information

Official study title

Assessment of Color Vision in Diabetic Patients Before and After the Use of Anti-vegf in the Treatment of Diabetic Macular Edema

Important dates

Study start: 2017
Primary completion: 2017
Study completion: 2017
First posted: Nov 17, 2017
Registry last updated: Nov 17, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed